NAP1L1

Nucleosome assembly protein 1-like 1 · P55209 · NAP1L1 on Sugi Atlas →

0 patent compounds predicted against NAP1L1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to NAP1L1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients PHASE3UNKNOWN
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
LBH589 Treatment for Refractory Clear Cell Renal Carcinoma PHASE2COMPLETED
A Multicenter Study of NAP (AL-108) in Schizophrenia PHASE2COMPLETED
An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab PHASE1/PHASE2RECRUITING
Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma PHASE1/PHASE2COMPLETED
Low-Dose Danazol for the Treatment of Telomere Related Diseases PHASE2COMPLETED
Phase 1/ Phase 2 Study to Assess Safety and Efficacy of Orally Administered JBI-802 in Subjects With Myeloproliferative Neoplasms (MPN) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) With Thrombocytosis PHASE1/PHASE2RECRUITING
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome PHASE1COMPLETED
A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers PHASE1COMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins nanCOMPLETED
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2 nanUNKNOWN
Genetics of Neonatal Encephalopathy and Related Disorders nanRECRUITING
Thermogenic Silencer Regulatory Factors in Humans nanACTIVE_NOT_RECRUITING
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Study of the Effect of Innate on the Inflammatory Response to Endotoxin nanRECRUITING
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus nanACTIVE_NOT_RECRUITING
H19 in Acute Lymphoblastic Leukemia. nanUNKNOWN
Quantitative Assessment of the Etiologies of Megalencephaly Associated With a Detectable Tumor Risk nanNOT_YET_RECRUITING
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia nanCOMPLETED
Impact of Weight Loss on the Human Sperm Epitranscriptome nanACTIVE_NOT_RECRUITING
Target of Suv420h1/2 in Hepatocytes nanRECRUITING
Lung Cancer Diagnosis by Detecting Epigenetic Imprinting Alterations in Bronchoalveolar Lavage nanUNKNOWN
Assessment Of Long Noncoding RNA CCAT1 In Colorectal Cancer Patients nanUNKNOWN
X-chromosome Inactivation, Epigenetics and the Transcriptome nanCOMPLETED
Effects of Cardiac Rehabilitation on High Mobility Group Box-1 Levels After Acute Myocardial Infarction nanCOMPLETED
Role of the Nuclear Pore Component RANBP2 in Inflammatory Responses to Viral Infections nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a NAP1L1 binder may also engage these)

ProteinNameSimilarity
A6H767 1.000 A6H767 →
P28656 1.000 P28656 →
Q9Z2G8 1.000 Q9Z2G8 →
Q5R4D4 1.000 Q5R4D4 →
Q28EB4 1.000 Q28EB4 →
Q7ZY81 1.000 Q7ZY81 →
Q4U0Y4 1.000 Q4U0Y4 →
Q5U2Z3 0.997 Q5U2Z3 →
NAP1L4 Nucleosome assembly protein 1-like 4 0.993 landscape →
Q2TA40 0.991 Q2TA40 →
Q78ZA7 0.989 Q78ZA7 →
Q69JW2 0.987 Q69JW2 →
B8AEC1 0.986 B8AEC1 →
Q9CA59 0.986 Q9CA59 →
Q7X7C9 0.984 Q7X7C9 →
Q53WK4 0.984 Q53WK4 →
Q70Z17 0.983 Q70Z17 →
Q8LC68 0.983 Q8LC68 →
Q94K07 0.983 Q94K07 →
P53997 0.982 P53997 →
Q9SZI2 0.982 Q9SZI2 →
Q70Z19 0.981 Q70Z19 →
B8AW64 0.981 B8AW64 →
B8B2R4 0.981 B8B2R4 →
O59797 0.981 O59797 →
Q63945 0.980 Q63945 →
Q3SYW6 0.980 Q3SYW6 →
Q17FR9 0.979 Q17FR9 →
A0A8I3P7X4 0.979 A0A8I3P7X4 →
A2XU85 0.979 A2XU85 →